# TenX Keane Acquisition (TENK)

Source: https://www.quantisnow.com/company/TENK
Generated: 2026-11-19T02:27:27.692Z

- Ticker: TENK
- Exchange: NASDAQ
- Sector: Finance
- Industry: Blank Checks
- IPO year: 2022

## Latest TENK news and filings

- 2024-08-15 16:53 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-tenx-keane-acquisition-5661033)
- 2024-08-14 22:29 UTC [SEC Form 4] [SEC Form 4 filed by Director Dutia Suren G](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-dutia-suren-g-5660210)
- 2024-08-14 22:28 UTC [SEC Form 4] [SEC Form 4 filed by Director Holubiak Myron Z](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-holubiak-myron-z-5660209)
- 2024-08-14 22:28 UTC [SEC Form 4] [SEC Form 4 filed by Chief Medical Officer Czuczman Myron](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-medical-officer-czuczman-myron-5660208)
- 2024-08-14 22:27 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Mazur Leonard L](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-mazur-leonard-5660207)
- 2024-08-14 22:26 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Bartushak Jaime](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-bartushak-jaime-5660206)
- 2024-08-14 22:26 UTC [SEC Form 4] [SEC Form 4 filed by Director Mcgrath Dennis M](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mcgrath-dennis-m-5660205)
- 2024-08-14 22:25 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Citius Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-citius-pharmaceuticals-inc-5660204)
- 2024-08-14 22:24 UTC [SEC Form 4] [SEC Form 4 filed by Director Webb Carol](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-webb-carol-5660203)
- 2024-08-14 22:24 UTC [SEC Form 3] [SEC Form 3 filed by new insider Dutia Suren G](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-dutia-suren-g-5660201)
- 2024-08-14 22:23 UTC [SEC Form 3] [SEC Form 3 filed by new insider Smith Robert Joseph](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-smith-robert-joseph-5660200)
- 2024-08-14 22:23 UTC [SEC Form 3] [SEC Form 3 filed by new insider Holubiak Myron Z](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-holubiak-myron-z-5660199)
- 2024-08-14 22:22 UTC [SEC Form 3] [SEC Form 3 filed by new insider Czuczman Myron](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-czuczman-myron-5660198)
- 2024-08-14 22:21 UTC [SEC Form 3] [SEC Form 3 filed by new insider Mazur Leonard L](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-mazur-leonard-l-5660197)
- 2024-08-14 22:20 UTC [SEC Form 3] [SEC Form 3 filed by new insider Bartushak Jaime](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-bartushak-jaime-5660195)
- 2024-08-14 22:20 UTC [SEC Form 3] [SEC Form 3 filed by new insider Mcgrath Dennis M](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-mcgrath-dennis-m-5660194)
- 2024-08-14 22:19 UTC [SEC Form 3] [New insider Citius Pharmaceuticals, Inc. claimed ownership of 65,627,262 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-citius-pharmaceuticals-inc-claimed-ownership-of-65627262-shares-5660193)
- 2024-08-14 22:19 UTC [SEC Form 3] [SEC Form 3 filed by new insider Webb Carol](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-webb-carol-5660192)
- 2024-08-13 20:33 UTC [SEC Form 25-NSE filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-tenx-keane-acquisition-5657257)
- 2024-08-09 20:22 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-tenx-keane-acquisition-5653070)
- 2024-08-09 11:30 UTC [TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update](https://www.quantisnow.com/insight/tenx-keane-acquisition-addresses-trading-halt-continues-towards-closing-of-5652056)
- 2024-08-05 12:00 UTC [TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals](https://www.quantisnow.com/insight/tenx-keane-acquisition-shareholders-approve-previously-announced-merger-to-form-5641454)
- 2024-08-05 12:00 UTC [Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.](https://www.quantisnow.com/insight/citius-pharmaceuticals-announces-tenx-keane-shareholder-approval-of-merger-with-5641444)
- 2024-08-03 00:45 UTC [SEC Form 8-K] [TenX Keane Acquisition filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tenx-keane-acquisition-filed-sec-form-8-k-leadership-update-submission-5641169)
- 2024-07-19 19:40 UTC [SEC Form 425] [SEC Form 425 filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-425-filed-by-tenx-keane-acquisition-5617744)
- 2024-07-19 19:39 UTC [SEC Form 8-K] [TenX Keane Acquisition filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tenx-keane-acquisition-filed-sec-form-8-k-entry-into-a-5617741)
- 2024-07-15 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-effect-filed-by-tenx-keane-acquisition-5607128)
- 2024-07-12 21:20 UTC [SEC Form 424B3] [SEC Form 424B3 filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-tenx-keane-acquisition-5606798)
- 2024-07-11 19:50 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-tenx-keane-acquisition-5604360)
- 2024-07-11 10:16 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-tenx-keane-acquisition-5602987)
- 2024-07-10 13:10 UTC [Public Offering] [Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates](https://www.quantisnow.com/insight/citius-pharmaceuticals-details-near-term-milestones-for-late-stage-candidates-5601288)
- 2024-06-18 17:36 UTC [SEC Form 425] [SEC Form 425 filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-425-filed-by-tenx-keane-acquisition-5564661)
- 2024-06-18 17:35 UTC [SEC Form 8-K] [TenX Keane Acquisition filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tenx-keane-acquisition-filed-sec-form-8-k-entry-into-a-5564660)
- 2024-06-17 21:30 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-tenx-keane-acquisition-5562880)
- 2024-06-06 21:29 UTC [SEC Form 425] [SEC Form 425 filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-425-filed-by-tenx-keane-acquisition-5543283)
- 2024-06-06 21:28 UTC [SEC Form 8-K] [TenX Keane Acquisition filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/tenx-keane-acquisition-filed-sec-form-8-k-other-events-5543281)
- 2024-05-21 19:07 UTC [SEC Form 8-K] [TenX Keane Acquisition filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tenx-keane-acquisition-filed-sec-form-8-k-entry-into-a-5507155)
- 2024-05-20 21:27 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-tenx-keane-acquisition-5505012)
- 2024-05-15 20:24 UTC [SEC Form NT 10-Q filed by TenX Keane Acquisition](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-tenx-keane-acquisition-5493725)
- 2024-05-03 21:05 UTC [SEC Form S-4] [SEC Form S-4/A filed by TenX Keane Acquisition (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-tenx-keane-acquisition-amendment-5459609)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TENK
- Earnings history: https://www.quantisnow.com/earnings/TENK
- Dividend history: https://www.quantisnow.com/dividends/TENK
- Insider transactions: https://www.quantisnow.com/insiders/TENK
- Options chain: https://www.quantisnow.com/options/TENK
- SEC 8-K filings only: https://www.quantisnow.com/company/TENK/8-k
- RSS and alerts for TENK: https://www.quantisnow.com/docs/rss-feeds.md
